tiprankstipranks
ArriVent BioPharma Reports First Quarter 2024 Financial Results
PremiumPress ReleasesArriVent BioPharma Reports First Quarter 2024 Financial Results
2M ago
ArriVent Biopharma reports Q1 EPS (70c), consensus ($1.10)
PremiumThe Fly
ArriVent Biopharma reports Q1 EPS (70c), consensus ($1.10)
2M ago
ArriVent Biopharma initiated with a Buy at H.C. Wainwright
PremiumThe Fly
ArriVent Biopharma initiated with a Buy at H.C. Wainwright
2M ago
Apple, Tesla downgraded: Wall Street’s top analyst calls
PremiumThe FlyApple, Tesla downgraded: Wall Street’s top analyst calls
5M ago
ArriVent Biopharma initiated with a Buy at Jefferies
PremiumThe Fly
ArriVent Biopharma initiated with a Buy at Jefferies
5M ago
ArriVent Biopharma initiated with a Buy at Citi
PremiumThe Fly
ArriVent Biopharma initiated with a Buy at Citi
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100